Samsung Electronics and IrisVision announced a strategic partnership to roll out IrisVision’s technology worldwide. IrisVision’s vision correction software platform utilizes the power of Samsung’s industry leading Galaxy smartphones and XR devices and mobile AI platform to enable people with impaired vision to see clearly and live more independent lives, according to a company news release.
Launched in 2017, IrisVision received registration as an FDA Class I medical device that same year. Over the past 2 years IrisVision has run clinical trials with Johns Hopkins, Stanford and UPMC. The company continues to extend its proprietary vision correction science to address more than 16 common eye conditions, including macular degeneration, diabetic retinopathy, and retinitis pigmentosa. IrisVision already has thousands of users around the world and received a CES 2019 Innovation Award recognizing its technology and customer success.
Within the partnership, IrisVision will continue to work with Samsung’s R&D and alliance partnership teams to further expand the use of Samsung technologies, including 5G mobile phones, Bixby AI platform and XR headsets. Also, Samsung will help IrisVision scale connected healthcare for the visually impaired community.
“At Samsung, we aim to not only build great mobile solutions but also to give our key partners mobile technology platforms to develop and provide their own innovation. It is amazing to see what IrisVision is doing to enable the large and underserved low vision community to live more independently,” Edward Choi, Corporate Vice President of Global Strategic Alliances at Mobile Communications Division, Samsung Electronics, said in the news release. “We will help guide IrisVision on technology integration and market strategy to ultimately help every affected patient.”
“Our vision science requires substantial computational power, quality optics, and a platform we can use to securely connect patients to providers and the digital world, all of which Samsung’s mobile and XR devices provide today,” IrisVision CEO and Co-founder Ammad Khan said in the news release. “With this partnership, Samsung’s technology and support, along with its global channels and partner network, will also enable the next generation of IrisVision products to diagnose and treat conditions remotely anywhere in the world.”